Skip to main content

NCBiotech News

  • Steven Nichtberger, M.D., has resigned as president, CEO and board member of Tengion, a Pennsylvania company commercializing regenerative medicine discoveries of Wake Forest University scientist Anthony Atala, M.D. More
  • Mark Phillips, Executive Director of the North Carolina Biotechnology Center, Eastern Region, presents Roger Conner, Interim Director of Go-Science, sponsorship funds for STEM  (Science, Technology, Engineering and Mathmatics summer camps. -Thomasyne Jefferson
  • Mark Phillips, Executive Director of the North Carolina Biotechnology Center, Eastern Region, presents John Bray, Executive Director, A Time for Science, sponsorship funds to assist with STEM (Science, Technology, Engineering and Mathmatics) Summer camps for the youth. -Thomasyne Jefferson
  • BioPontis Alliance has added Pfizer and Janssen Biotech to its list of collaborators that are commercializing drug research from the University of North Carolina at Chapel Hill and other institutions. The Raleigh company announced the agreements this week at the 2011 BIO International Convention in Washington, D.C.
  • The revolutionary flu vaccine being developed by Medicago for production in its nearly completed Research Triangle Park manufacturing facility is behaving just as the company hoped.
  • Pappas Ventures' managing partner Arthur M. Pappas has some advice for startups today at BIO 2011 in Washington D.C. The session topic is "Starting Up Biotechs in the New Normal." With talk at the Ernst and Young panel on Tuesday about doing more with less, Pappas and his fellow panel members will have valuable advice for those trying to make it in life sciences today. The panel begins at 10 a.m.  in room 149 A/B.
  • Whether the issue is partnering, supply chain or the next big thing in ag biotech, you'll find your answer at the Walter E. Washington Convention Center today. And North Carolina speakers have those answers. Today's topic titles themselves are filled with questions:
  • Amy Schaberg, former vice president of clinical research at Inspire Pharmaceuticals, has been hired as vice president of operations at the fast-growing Chapel Hill contract research organization Rho. More
  • It’s a big deal for North Carolina and the global agricultural biotechnology world, so the groundbreaking for Syngenta Biotechnology’s $70 million expansion today required a big shovel – in this case, an excavator made by North Carolina-based Volvo Construction Equipment.
  • A new crop of life-science companies is putting North Carolina on the map with some of the world's most efficient manufacturing plants. The companies are unique because plants are their plants – living bioreactors producing therapeutics, diagnostics and other valuable biological products.
  • The Research Triangle area is ready to fly high in July, connecting with more than 13 million people via a 38-page special section in the Delta Airlines Sky magazine.
  • The David H. Murdock Research Institute in Kannapolis is buying out a small research group that set up shop there in the summer of 2010 to study the human immune system. The Murdock organization is paying $250,000 in cash and absorbing the non-profit Immune Tolerance Institute’s six employees already working at the North Carolina Research Campus in Kannapolis.
  • North Carolina’s track record of job growth in the life sciences though the recession and its aftermath demonstrates that the state has been doing things right, a North Carolina Biotechnology Center executive said after participating in one of several federal Jobs and Competitiveness Council sessions in the Triangle today.
  • Veteran life-science executive Cynthia Verst, Pharm.D., senior vice president of global late-phase research at Ingenix, has been hired to lead the Quintiles late-phase operations group. More
  • Jim Blome has been named president, CEO and head of crop protection for the Research Triangle Park-based North American region at Bayer CropScience, to succeed the retiring Bill Buckner. More
  • The vaccine Medicago plans to produce from tobacco leaves at its new Research Triangle Park factory was safe and well tolerated in human volunteers involved in a Phase I clinical trial, the company has reported to the U.S. Food and Drug Administration.
  • MdxHealth, a Belgian diagnostics company with U.S. headquarters in Durham, has reported success in a Phase III clinical study identifying brain-cancer patients who are the best candidates for chemotherapy. More
  • MdxHealth, a Belgian diagnostics company with U.S. headquarters in Durham, has reported success in a Phase III clinical study identifying brain-cancer patients who are the best candidates for chemotherapy. More
  • The Fujifilm Diosynth Biotechnologies contract-manufacturing facility in Morrisville is being expanded just two months after being purchased by its new Japanese parent, FUJIFILM Corporation. The 370-employee factory, which produces ingredients used in biotechnology drugs, will expand its mammalian and insect cell-culture capabilities with a new 1,000-liter bioreactor, additional mixers and filtration equipment.
  • ASHEVILLE, N.C. June 2, 2011 – Jonathon Lawrie, Ph.D., assistant professor at the Western Carolina University College of Business’s Center for Entrepreneurship and Innovation, has joined the North Carolina Biotechnology Center as executive director of the Western Office. Lawrie is an educator, entrepreneur and scientist whose career has included R&D and management at major pharmaceutical companies as well as the co-founding of several biotechnology companies.

Pages

Subscribe to News & Events